Protalix BioTherapeutics
PLX
PLX
28 hedge funds and large institutions have $11.5M invested in Protalix BioTherapeutics in 2017 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 12 closing their positions.
Holders
28
Holders Change
-5
Holders Change %
-15.15%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
9
Reduced
5
Closed
12
Calls
$261K
Puts
$348K
Net Calls
-$87K
Net Calls Change
-$87K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$2.62M |
2 |
ARTA
2
A.R.T. Advisors
New York
|
$291K |
3 |
![]()
3
Simplex Trading
Chicago,
Illinois
|
$174K |
4 |
WAM
4
Wolverine Asset Management
Chicago,
Illinois
|
$142K |
5 |
5
BlackRock
New York
|
$139K |